Citation

Blass BE, Fensome A, Trybulski E, Magolda R, Gardell SJ, Liu K, Samuel M, Feingold I, Huselton C, Jackson CM, Djandjighian L, Ho D, Hennan J, Janusz JM.: Selective Kv1.5 blockers: development of (R)-1-(methylsulfonylamino)-3-[2-(4-methoxyphenyl)ethyl]-4-(4-methoxyphenyl)-2-imidazolidinone (KVI-020/WYE-160020) as a potential treatment for atrial arrhythmia. J Med Chem, Volume 52 (21), 2009

Authors

Blass BE, Djandjighian L, Feingold I, Fensome A, Gardell SJ, Hennan J, Ho D, Huselton C, Jackson CM, Janusz JM., Liu K, Magolda R, Samuel M, Trybulski E

Journal

J Med Chem

Year

2009

DOI

10.1021/jm901042m

PubMed

19888755

Machine-readable

REST APIRDF